|
Research Management and Support - Total
|
RMS2012 [E]
|
$374,919,382
|
$44,990
|
N/A
|
(NCI)
|
|
Molecular Targeted Photoimmunotherapy for Bladder Cancer
|
ZIABC011458
|
$434,685
|
$434,685
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIABC010030
|
$806,557
|
$80,656
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Bladder Cancer Program
|
ZIABC011351
|
$141,888
|
$141,888
|
Apolo, Andrea
|
CCR (NCI)
|
|
SOUTHEAST CANCER CONTROL COSORTIUM, INC
|
3U10CA045808-18S1
|
$323,511
|
$3,235
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-26
|
$1,476,477
|
$14,765
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
San Juan Minority - Based Community Clinical Oncology Program
|
5U10CA052667-22
|
$536,603
|
$5,366
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
SWOG Community Clinical Oncology Program Research Base
|
2U10CA037429-28
|
$1,371,233
|
$27,425
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group Treatment Grant
|
3U10CA032102-33S1
|
$196,749
|
$7,870
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group Treatment Grant
|
5U10CA032102-33
|
$8,923,498
|
$356,940
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIABC011232
|
$306,950
|
$306,950
|
Barchi, Joseph
|
CCR (NCI)
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-15
|
$349,322
|
$10,480
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIABC010620
|
$90,730
|
$22,682
|
Bates, Susan
|
CCR (NCI)
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIABC010622
|
$226,824
|
$45,365
|
Bates, Susan
|
CCR (NCI)
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-28
|
$820,953
|
$8,210
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
The Gulf Coast MBCCOP
|
3U10CA128536-05S1
|
$391,891
|
$3,919
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
Iowa Oncology Research Association
|
2U10CA035101-27
|
$669,579
|
$6,696
|
BEHRENS, ROBERT
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
5U10CA063844-19
|
$543,533
|
$5,435
|
Berenberg, Jeffrey
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Cancer and Leukemia Group B
|
3U10CA031946-31S1
|
$114,228
|
$3,427
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-27S1
|
$405,901
|
$4,059
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA031946-31
|
$7,759,618
|
$232,789
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-28
|
$2,286,202
|
$22,862
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIABC011470
|
$232,561
|
$93,024
|
Beutler, John
|
CCR (NCI)
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
5U10CA142559-03
|
$131,854
|
$5,274
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-15
|
$487,632
|
$14,629
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma
|
ZIABC011095
|
$115,347
|
$115,347
|
Bottaro, Donald
|
CCR (NCI)
|
|
Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics
|
ZIABC011123
|
$69,208
|
$34,604
|
Bottaro, Donald
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIABC011124
|
$276,834
|
$96,892
|
Bottaro, Donald
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIABC011460
|
$279,821
|
$195,875
|
Buck, Christopher
|
CCR (NCI)
|
|
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents
|
ZIABC006198
|
$656,535
|
$492,401
|
Burke, Terrence
|
CCR (NCI)
|
|
Cancer and Leukemia Group B
|
5U10CA032291-31
|
$495,751
|
$14,873
|
Burstein, Harold
|
DANA-FARBER CANCER INSTITUTE
|
|
Families at high risk of cancer
|
ZIA CP004410-08285
|
$1,137,642
|
$113,764
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Ozark Health Ventures, LLC dba Cancer Research for the Ozarks
|
5U10CA045560-24
|
$731,095
|
$7,311
|
Carolla, Robert
|
OZARK HEALTH VENTURES, LLC
|
|
Columbia River Oncology Program
|
5U10CA045377-26
|
$986,419
|
$9,864
|
Conlin, Alison
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
Cancer and Leukemia Group B
|
5U10CA047577-25
|
$99,190
|
$2,976
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Radiation Therapy Oncology Group
|
3U10CA021661-36S1
|
$172,284
|
$1,723
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
5U10CA021661-36
|
$12,915,055
|
$129,151
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIGBC010856
|
$14,609,987
|
$730,499
|
Custer, Mary
|
CCR (NCI)
|
|
Community Clinical Oncology Program
|
5U10CA035431-29
|
$2,077,111
|
$20,771
|
DAKHIL, SHAKER
|
VIA CHRISTI REGIONAL MEDICAL CENTER
|
|
CANCER AND INFLAMMATION GENETICS
|
ZIABC011300
|
$619,559
|
$185,868
|
Dean, Michael
|
CCR (NCI)
|
|
Molecular Modeling of the Human P-glycoprotein Transporter Protein
|
ZICBC011075
|
$53,996
|
$26,998
|
Durell, Stewart
|
CCR (NCI)
|
|
Molecular Profiling of Clinical Specimens
|
ZICBC011040
|
$1,320,590
|
$184,883
|
Edelman, Daniel
|
CCR (NCI)
|
|
University of Colorado Southwest Oncology Group
|
5U10CA042777-25
|
$1
|
$0
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Nevada Cancer Research foundation-Community Clinical Oncology Program
|
2U10CA035421-29
|
$713,534
|
$7,135
|
ELLERTON, JOHN
|
SOUTHERN NEVADA CANCER RESEARCH FDN
|
|
Clinical production of viral vectors for cancer gene therapy
|
ZICBC010989
|
$335,259
|
$16,763
|
Feldman, Steven
|
CCR (NCI)
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
$4,862
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
|
ZICBC010548
|
$435,929
|
$43,593
|
Figg, William
|
CCR (NCI)
|
|
Quality Assurance Review Center
|
5U10CA029511-33
|
$1,668,149
|
$16,681
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Southwest Oncology Group U10 Member Site
|
5U10CA014028-39
|
$319,062
|
$12,762
|
FLAHERTY, LAWRENCE
|
WAYNE STATE UNIVERSITY
|
|
Metro-Minnesota Community Clinical Oncology Program
|
5U10CA035267-29
|
$2,406,035
|
$24,060
|
Flynn, Patrick
|
PARK NICOLLET INSTITUTE
|
Total relevant funding to Urinary System for this search: $17,920,625
|